Physician profile
Daniel Howard
NPI 1336136514
$21,842.33
in general payments reported to CMS, 2019-2025
34 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $1,127 · 2021: $6,360 · 2022: $6,804 · 2023: $2,657 · 2024: $3,015 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,076 · Consulting Fee: $1,500 · Travel and Lodging: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,076.37 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $208.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $8,917.87 | 2021-2024 | |
| Tela Bio, INC. | $3,779.94 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $3,136.81 | 2019-2022 | |
| Sirius Medical Systems | $1,048.79 | 2023 | Pintuition |
| Dilon Technologies, INC. | $735.87 | 2022-2025 | Hemoblast Bellows |
| Abbvie INC. | $692.43 | 2022-2025 | |
| Integra Lifesciences Corporation | $610.95 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Elucent Medical | $321.36 | 2020 | |
| Merck Sharp & Dohme LLC | $293.00 | 2022-2025 | Keytruda, Lynparza |
| Pacira Pharmaceuticals Incorporated | $255.34 | 2020-2023 | Exparel |
| Astrazeneca Pharmaceuticals Lp | $223.75 | 2023-2024 | Enhertu |
| Stryker Corporation | $208.00 | 2025 | 1788 |
| Hologic Sales and Service, LLC | $195.93 | 2022-2023 | Localizer, Brevera Breast Biopsy System, Trident Specimen Radiography System |
| Ethicon US, LLC | $195.86 | 2019 | |
| Hologic INC | $179.27 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icad, INC | $147.28 | 2021 | |
| Ge Healthcare | $124.62 | 2023 | |
| Focal Therapeutics, INC. | $122.60 | 2019-2021 | |
| Inspire Medical Systems, INC. | $119.33 | 2024 | Inspire |
| Tactile Systems Technology INC | $117.78 | 2020-2022 | |
| Gilead Sciences, INC. | $96.20 | 2023 | Trodelvy |
| Stemline Therapeutics INC. | $80.88 | 2023 | Orserdu |
| Musculoskeletal Transplant Foundation INC. | $45.20 | 2025 | |
| Davol INC. | $24.20 | 2022 | |
| Bard Peripheral Vascular, INC. | $23.43 | 2019 | |
| Innocoll Pharmaceuticals Limited | $23.27 | 2022 | |
| Kci USA, INC. | $19.33 | 2019 | |
| Melinta Therapeutics, LLC | $17.41 | 2019 | |
| Smith+Nephew, INC. | $16.80 | 2019 | |
| Merit Medical Systems INC | $15.13 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.17 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $13.73 | 2019 | |
| Boston Scientific Corporation | $13.05 | 2022 | |
| Ambu INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.